Increase of number of shares and votes in Vicore Pharma
Gothenburg, January 31, 2020 – Vicore Pharma Holding AB (publ)’s (“Vicore Pharma”) registered share capital and number of outstanding shares and votes have increased during the month of January 2020.
The number of shares and votes in Vicore Pharma in January 2020 increased through the exercising of warrants under a warrant program for key employees and key researchers in Vicore. The warrants were issued in January 2016. The total number of shares and votes has increased by 243,525.
As of today, the total number of registered and outstanding shares and votes of Vicore Pharma amounts to 50,418,239. Furthermore, the registered share capital amounts to SEK 25,209,119.
For further information, please contact:
Carl-Johan Dalsgaard, CEO, tel: +46 70 975 98 63, firstname.lastname@example.org
Hans Jeppsson, CFO, tel: +46 70 553 14 65, email@example.com
This information is information that Vicore Pharma Holding AB (publ) is obliged to make public pursuant to the Financial Instruments Trading Act. The information was submitted for publication, through the agency of the contact persons set out above, on 31 January 2020 at 08:00 CET.